Tuesday, December 8, 2020

Regulus Therapeutics Finds $19.4M In Private Placement

La Jolla-based biopharmaceuticals company Regulus Therapeutics announced this morning that it has raised $19.4M in a private placement. The publicly traded company, which trades on the Nasdaq as RGLS, said it sold 24,341,607 shares of the Company's common stock and accompanying warrants to purchase up to an aggregate of 18,256,204 shares of common stoc

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.